The primary biomarkers used to diagnose CIRS are: (1) Visual Contrast Sensitivity (VCS) test—abnormally low sensitivity indicating retinal microcirculation dysfunction; (2) HLA-DR genetic susceptibility; (3) Melanocyte-stimulating hormone (MSH)—abnormally low; (4) Cytokine levels—abnormally elevated; (5) TGF-beta-1 (transforming growth factor beta 1)—abnormally elevated. These biomarkers are chosen because they are validated to separate cases from healthy controls and show objective improvement with treatment.
definitionpending
Speaker
Richie ShoemakerEvidence Quote
“[37:26] 'VCS was our first HLA was our next... melanoid stimulating hormone which is essentially negative in all cases'”
Source
Worse Than Asbestos? The CIRS Rabbit Hole | Dr. Scott McMahon & Dr. Ritchie Shoemaker | EP 415— Jordan B PetersonCreated: 8/12/2026, 6:04:29 PM
Your notes
Loading notes...